DE69932187D1 - Verbindungen für krebs-therapie - Google Patents

Verbindungen für krebs-therapie

Info

Publication number
DE69932187D1
DE69932187D1 DE69932187T DE69932187T DE69932187D1 DE 69932187 D1 DE69932187 D1 DE 69932187D1 DE 69932187 T DE69932187 T DE 69932187T DE 69932187 T DE69932187 T DE 69932187T DE 69932187 D1 DE69932187 D1 DE 69932187D1
Authority
DE
Germany
Prior art keywords
compounds
doxorubicin
cancer therapy
potency
presented
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69932187T
Other languages
English (en)
Other versions
DE69932187T2 (de
Inventor
Oleg Strechenok
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ardenia Investments Ltd
Original Assignee
Ardenia Investments Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9900878A external-priority patent/SE9900878D0/xx
Priority claimed from SE9900941A external-priority patent/SE9900941D0/xx
Application filed by Ardenia Investments Ltd filed Critical Ardenia Investments Ltd
Application granted granted Critical
Publication of DE69932187D1 publication Critical patent/DE69932187D1/de
Publication of DE69932187T2 publication Critical patent/DE69932187T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C07H15/252—Naphthacene radicals, e.g. daunomycins, adriamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69932187T 1999-03-11 1999-12-28 Verbindungen für krebs-therapie Expired - Lifetime DE69932187T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
SE9900878 1999-03-11
SE9900878A SE9900878D0 (sv) 1998-12-23 1999-03-11 New composition and use thereof
SE9900941 1999-03-16
SE9900941A SE9900941D0 (sv) 1998-12-23 1999-03-16 Novel retinoic acid derivatives and their use
PCT/IB1999/002062 WO2000042832A2 (en) 1999-03-11 1999-12-28 New compounds for the treatment of cancer

Publications (2)

Publication Number Publication Date
DE69932187D1 true DE69932187D1 (de) 2006-08-10
DE69932187T2 DE69932187T2 (de) 2007-05-24

Family

ID=26663529

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69932187T Expired - Lifetime DE69932187T2 (de) 1999-03-11 1999-12-28 Verbindungen für krebs-therapie

Country Status (10)

Country Link
EP (1) EP1159756B1 (de)
JP (1) JP4643009B2 (de)
CN (1) CN1149219C (de)
AT (1) ATE332013T1 (de)
AU (1) AU766256B2 (de)
CA (1) CA2358420C (de)
DE (1) DE69932187T2 (de)
HK (1) HK1041889B (de)
ID (1) ID29246A (de)
WO (1) WO2000042832A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1161436B1 (de) * 1999-03-16 2003-06-25 Ardenia Investments Ltd. Polyungesättigte Fettsäurederivate und deren Verwendung in der Krebsbehandlung
AU2001268007A1 (en) * 2000-07-12 2002-01-21 Ardenia Investments Ltd. Novel cytotoxic compounds and their use
US6613753B2 (en) * 2001-02-21 2003-09-02 Supergen, Inc. Restore cancer-suppressing functions to neoplastic cells through DNA hypomethylation
AUPR395801A0 (en) * 2001-03-26 2001-04-26 Austin Research Institute, The Antibodies against cancer
WO2009078755A1 (en) * 2007-12-19 2009-06-25 Ardenia Investments, Ltd. Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance
WO2009078756A1 (en) * 2007-12-19 2009-06-25 Ardenia Investments, Ltd. Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance
JP7041673B2 (ja) * 2016-10-13 2022-03-24 カーノット， エルエルシー Ｎ－アシルエタノールアミド誘導体およびその使用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI101678B (fi) * 1990-12-31 1998-08-14 Akzo Nv Happolabiileja kytkentämolekyylejä

Also Published As

Publication number Publication date
DE69932187T2 (de) 2007-05-24
JP4643009B2 (ja) 2011-03-02
ID29246A (id) 2001-08-16
CN1332745A (zh) 2002-01-23
CA2358420C (en) 2010-03-16
EP1159756A2 (de) 2001-12-05
JP2002535251A (ja) 2002-10-22
HK1041889A1 (en) 2002-07-26
CA2358420A1 (en) 2000-07-27
EP1159756B1 (de) 2006-06-28
HK1041889B (zh) 2005-03-18
WO2000042832A3 (en) 2001-02-01
CN1149219C (zh) 2004-05-12
ATE332013T1 (de) 2006-07-15
WO2000042832A2 (en) 2000-07-27
AU766256B2 (en) 2003-10-09
AU1581800A (en) 2000-08-07

Similar Documents

Publication Publication Date Title
DE69925276D1 (de) Stoffe und zusammensetzungen für die verabreichung aktiver substanzen
UA88464C2 (ru) Способ дермального введения метадоновой композиции с обеспечением системного действия
AR019855A1 (es) Uso de conjugados de peg-ifn-alfa y ribavirina para la fabricacion de un medicamento para el tratamiento de hepatitis c cronica
TR200000576T1 (tr) Lipozomal kapsüllenmiş taksan uygulanması için bir yöntem
DE60335797D1 (de) Lösliche formulierungen, die monomeres insulin und acyliertes insulin enthalten
WO2000006134A3 (en) Use of l-carnitine and its alkanoyl derivatives in the preparation of medicaments with anticancer activity
HN2001000244A (es) Inhibidores de espiropirimidin - 2, 4, 6 - triona metaloproteinasas.
TR200103525T2 (tr) Bisiklik poliaminosit metal kompleksleri, bunları hazırlamak için yöntem ve bunların tıbbi görüntülemede kullanımı.
AR035977A1 (es) Inmunoconjugados de anticuerpos cd44 citotoxicos.
DE60134274D1 (en) Complex enthaltend modafinil und cyclodextrin
AR032293A1 (es) Estuche farmaceutico
BR0213424A (pt) Uso aperfeiçoado de composto antitumoral na terapia contra câncer
MY138883A (en) Use of asiatic acid for treatment of cencer
ATE332013T1 (de) Verbindungen für krebs-therapie
AU2002214389A1 (en) Pharmaceutical composition containing honey for the treatment of wounds
TR200103271T2 (tr) İnflamasyon aracılığıyla gerçekleşen infeksiyon için anti-inflamatuar tedavi.
RS53804A (en) Parenteral composition of paracetamol
DE60113445D1 (de) Substanzen mit verzweigten linkermolekülen
NO20023551D0 (no) Ibuprofen-inneholdende aktivt middel-preparat
HUP0203153A2 (hu) Kombinációs kemoterápia
MY128859A (en) Compounds for the treatment of cancer
TR200302193T4 (tr) Kombinasyon kemoterapisi.
EP1374873B8 (de) Verwendung von n-acetyl-d-glucosamin bei der herstellung eines arzneimittels zur unterdrückung der nebenwirkungen von strahlentherapie und chemotherapie
DE60006284D1 (de) Arzneimittel zur behandlung konvulsivischer zustände
GB0128071D0 (en) Medicament

Legal Events

Date Code Title Description
8364 No opposition during term of opposition